Title : Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated
R47H variant of the immune
receptor TREM2
Abstract :
- Triggering receptor expressed on myeloid cells 2 ( TREM2 ) is an immune receptor expressed on the surface of microglia, macrophages, dendritic cells, and osteoclasts
- The R47H TREM2 variant is a significant risk factor for late-onset Alzheimer's disease (AD), and the molecular basis of R47H TREM2 loss of function is an emerging area of TREM2 biology
- Here, we report three high-resolution structures of the extracellular ligand-binding domains (ECDs) of R47H TREM2 , apo-WT, and phosphatidylserine (PS)-bound WT TREM2 at 1.8, 2.2, and 2.2 Å, respectively
- The structures reveal that Arg47 plays a critical role in maintaining the structural features of the complementarity-determining region 2 (CDR2 ) loop and the putative positive ligand-interacting surface (PLIS), stabilizing conformations capable of ligand interaction
- This is exemplified in the PS-bound structure, in which the CDR2 loop and PLIS drive critical interactions with PS via surfaces that are disrupted in the variant
- Together with in vitro and in vivo characterization, our structural findings elucidate the molecular mechanism underlying loss of ligand binding, putative oligomerization, and functional activity of R47H TREM2
- They also help unravel how decreased in vitro and in vivo stability of TREM2 contribute to loss of function in disease
Output (sent_index, trigger,
protein,
sugar,
site):
Output(Part-Of) (sent_index,
protein,
site):
- 3. TREM2, domains
- 3. WT TREM2, domains
- 3. apo, domains
*Output_Site_Fusion* (sent_index,
protein,
sugar,
site):